These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10370166)

  • 1. Transdermal iontophoretic delivery of enoxacin from various liposome-encapsulated formulations.
    Fang JY; Sung KC; Lin HH; Fang CL
    J Control Release; 1999 Jun; 60(1):1-10. PubMed ID: 10370166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of liposomes and niosomes on skin permeation of enoxacin.
    Fang JY; Hong CT; Chiu WT; Wang YY
    Int J Pharm; 2001 May; 219(1-2):61-72. PubMed ID: 11337166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model.
    Fang JY; Hsu LR; Huang YB; Tsai YH
    Int J Pharm; 1999 Apr; 180(2):137-49. PubMed ID: 10370184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and stability of various liposome-encapsulated enoxacin formulations.
    Fang JY; Lin HH; Hsu LR; Tsai YH
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1504-9. PubMed ID: 9332003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
    Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation on transdermal delivery of enoxacin via chemical enhancers and physical iontophoresis.
    Fang JY; Lin HH; Chen HI; Tsai YH
    J Control Release; 1998 Aug; 54(3):293-304. PubMed ID: 9766249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal iontophoretic delivery of enkephalin formulated in liposomes.
    Vutla NB; Betageri GV; Banga AK
    J Pharm Sci; 1996 Jan; 85(1):5-8. PubMed ID: 8926583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
    Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
    Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
    Conjeevaram R; Chaturvedula A; Betageri GV; Sunkara G; Banga AK
    Pharm Res; 2003 Sep; 20(9):1496-501. PubMed ID: 14567646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis.
    Han I; Kim M; Kim J
    Exp Dermatol; 2004 Feb; 13(2):86-92. PubMed ID: 15009101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery.
    Essa EA; Bonner MC; Barry BW
    J Pharm Pharmacol; 2002 Nov; 54(11):1481-90. PubMed ID: 12495550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
    Uchino T; Lefeber F; Gooris G; Bouwstra J
    Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iontophoretic Mediated Intraarticular Delivery of Deformable Liposomes of Diclofenac Sodium.
    Vanaja K; S S; Murthy SN; Shivakumar HN
    Curr Drug Deliv; 2021; 18(4):421-432. PubMed ID: 33059549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future drug delivery research in South Korea.
    Chung SJ
    J Control Release; 1999 Nov; 62(1-2):73-9. PubMed ID: 10518638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal and intradermal iontophoretic delivery of dexamethasone sodium phosphate: quantification of the drug localized in skin.
    Paturi J; Kim HD; Chakraborty B; Friden PM; Banga AK
    J Drug Target; 2010 Feb; 18(2):134-40. PubMed ID: 19772394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant.
    Essa EA; Bonner MC; Barry BW
    J Control Release; 2004 Mar; 95(3):535-46. PubMed ID: 15023464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.